The Ascendance Of Genomics In Meeting The Demand For Advanced Cancer Diagnostics: Critical Driver Shaping the Genomics In Cancer Care Market in 2025

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

Genomics In Cancer Care Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for genomics in cancer care has witnessed a swift escalation in past years. It is set to expand from $17.6 billion in 2024 to $20.73 billion in 2025, registering a compound annual growth rate (CAGR) of 17.8%. Factors such as early-stage research and development, advancement in companion diagnostics, the establishment of ethical and legal frameworks, standardization and interpretation of data, and initial market penetration have contributed to the growth during the historic period.

Genomics In Cancer Care Market Size Forecast: What's the Projected Valuation by 2029?
The market size of genomics in cancer care is predicted to witness a swift expansion in the coming years. It is projected to reach $38.57 billion by 2029, with the compound annual growth rate (CAGR) estimated at 16.8%. Elements contributing to this growth in the forecasted period include the rising frequency of cancer, progress in data analytics, market growth in burgeoning economies, safety and privacy of genomic data, and enhancement of healare facilities. Key trends forecasted to shape this period comprise technological progressions, tailored medicine, declining costs of genomic sequencing, regulatory backing and guidelines, and heightened patient awareness and demand.

View the full report here:
https://www.thebusinessresearchcompany.com/report/genomics-in-cancer-care-global-market-report

What Are the Drivers Transforming the Genomics In Cancer Care Market?
The surge in the need for cancer diagnostic procedures is predicted to fuel the genomics in cancer care market. Cancer diagnostics involve identifying the precise type, location, extent, and stage of the tumor through tests and procedures that confirm the presence of the disease. By understanding the genetic backgrounds of patients, genomics in cancer care can determine the most effective treatment plan. For illustration, The Cancer Research UK, a cancer research organization based in the UK, projected in July 2024 that the average yearly count of new cancer cases in the UK will likely grow from an estimated 420,000 cases in the period 2023-2025 to approximately 506,000 cases by the years 2038-2040. As such, the escalating demand for cancer diagnostics is anticipated to bolster the genomics in the cancer care market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8159&type=smp

What Long-Term Trends Will Define the Future of the Genomics In Cancer Care Market?
Leading players in the genomics in cancer care market are concentrating on the development of robotic genomic testing facilities to improve the precision and productivity of genetic testing, decrease timing of results, and advance patient results through the implementation of individualized treatment plans based on genetic profiles. The term robotic genomic testing facilities is used to categorize sophisticated laboratory environments that are equipped with automated processes and robotic technologies intended for different genomic investigations. By leveraging the LINQ platform by Automata, these labs use six robotic arms that automate the setup of various samples like saliva, blood, bone marrow, and tissue biopsies. For example, in September 2024, The Royal Marsden NHS Foundation Trust, a UK-based cancer hospital, introduced its robotic genomic testing facilities with the aim of improving cancer detection and treatment. This facility will allow Royal Marsden to double its genomic testing capacity, enabling the processing of a higher number of tests without sacrificing precision.

Which Segments in the Genomics In Cancer Care Market Offer the Most Profit Potential?
The genomics in cancer care market covered in this report is segmented -

1) By Product Type: Instruments, Consumables, Services
2) By Technology: PCR (?Polymerase Chain Reaction), MicroArrays, Genome Sequencing, Other Technologies
3) By Application: Diagnostics, Personalized Medicine, Drug Discovery And Development, Research
4) By End-User: Hospitals, Government Institutes, Research Facilities

Subsegments:
1) By Instruments: Sequencers, PCR Machines, Microarrays, Other Diagnostic Instruments
2) By Consumables: Reagents And Kits, Sample Preparation Products, Nucleotides, Other Consumables
3) By Services: Data Analysis Services, Bioinformatics Services, Genetic Testing Services, Other Support Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8159&type=smp

Which Firms Dominate the Genomics In Cancer Care Market by Market Share and Revenue in 2025?
Major companies operating in the genomics in cancer care market are Illumina Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., Danaher Corporation, Pacific Biosciences of California Inc., Roche Holding AG, Quest Diagnostics Incorporated, DiaSorin S.p.A., BGI Group, Myriad Genetics Inc., NeoGenomics Laboratories, Foundation Medicine Inc., Intermountain Healare, Laboratory Corporation of America Holdings, Flatiron Health Inc., Personal Genome Diagnostics Inc., Natera Inc., GRAIL Inc., Freenome Holdings Inc., Caris Life Sciences Inc., Tempus Labs Inc., OncoDNA S.A., Biocept Inc., GenomOncology Corp., OncoCyte Corporation, PathAI Inc., Enzyme Corporation, Karius Inc., N-of-One Inc., Oncora Medical Inc., Paradigm Diagnostics Inc., PierianDx Inc., Predicine Inc., Resolution Bioscience Inc., Strata Oncology Inc.

Which Regions Offer the Highest Growth Potential in the Genomics In Cancer Care Market?
North America was the largest region in the genomics in cancer care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomics in cancer care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8159

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.